Genmab A/S (GB:0MGB)

Genmab A/S (0MGB) Financial Statements


Genmab A/S Financial Overview

Genmab A/S's market cap is currently ―. The company's EPS TTM is kr66.656; its P/E ratio is 29.26; Genmab A/S is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is kr11.94. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--kr 4.09Bkr 3.16Bkr 2.12B
Gross Profit-----
EBIT--kr 3.28Bkr 2.69Bkr 616.00M
EBITDA--kr 3.28Bkr 2.69Bkr 616.00M
Net Income Common Stockholders--kr 2.58Bkr 1.89Bkr 465.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 28.14Bkr 22.32Bkr 23.79Bkr 21.61Bkr 19.99B
Total Assetskr 35.29Bkr 30.28Bkr 30.69Bkr 27.48Bkr 24.91B
Total Debtkr 770.00Mkr 597.00Mkr 629.00Mkr 634.00Mkr 416.00M
Net Debtkr -27.36Bkr -21.73Bkr -23.16Bkr -20.98Bkr -19.57B
Total Liabilitieskr 3.68Bkr 2.84Bkr 4.03Bkr 2.99Bkr 2.19B
Stockholders Equitykr 31.61Bkr 27.44Bkr 26.66Bkr 24.48Bkr 22.72B
Cash Flow-
Free Cash Flow--kr 1.89Bkr 891.00Mkr 530.00M
Operating Cash Flow--kr 1.97Bkr 959.00Mkr 587.00M
Investing Cash Flow--kr -1.38Bkr -576.00Mkr -667.00M
Financing Cash Flow--kr -642.00Mkr -214.00Mkr -64.00M
Currency in DKK

Genmab A/S Earnings and Revenue History

Genmab A/S Debt to Assets

Genmab A/S Cash Flow

Genmab A/S Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis